James Randleman, MD
Primary Location
Cleveland Clinic Main Campus
- Appointment:
- 216.444.8158
- Desk:
- 216.444.2030
- Fax:
- 216.445.8475
Treatment & Services
- Cataract Evaluations
- Corneal Collagen Cross-Linking
- LASIK (Laser in situ Keratomileusis)
- Phacoemulsification
- Photorefractive Keratectomy (PRK) Eye Surgery
- Refractive Cataract Surgery
- Refractive Lens Exchange
- Refractive Surgery
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout James Randleman, MD
J. Bradley Randleman, MD, is a Professor of Ophthalmology at the Cole Eye Institute of the Cleveland Clinic Foundation in Cleveland Ohio. He was previously Professor of Ophthalmology at the Keck School of Medicine of USC and Director of the Cornea & Refractive Surgery Service at the USC Roski Eye Institute in Los Angeles, California and the Hughes Professor of Ophthalmology at Emory University and Director of the Cornea Section at the Emory Eye Center. A widely respected cornea specialist, his areas of expertise include: corneal and intraocular refractive surgical procedures including LASIK and premium laser-assisted cataract and IOL surgery, complicated cataract surgery, and the management of corneal ectatic disorders. His primary research focuses on identification and management of corneal ectatic diseases including keratoconus and postoperative ectasia after LASIK, and the avoidance, diagnosis, and management of refractive surgical complications. He was awarded multiple grants, including an R01 from the NIH to evaluate corneal biomechanical analysis using Brillouin Microscopy.
Dr. Randleman received his BA degree from Columbia College at Columbia University in New York City, his M.D. degree from Texas Tech University School of Medicine in Lubbock, Texas, where he was elected to the Alpha Omega Alpha medical honor society in his junior year, followed by his Ophthalmology residency at Emory University in Atlanta, Georgia. Dr. Randleman joined the Emory faculty and served as Assistant Residency Director for two years while also completing a fellowship in Cornea/External Disease, and Refractive Surgery at Emory University. He served as Director of the Emory Corneal Fellowship program until taking over as Director of the Cornea Service in 2010 and was named the Hughes Professor of Ophthalmology in 2016.
Dr. Randleman has been awarded the Claus Dohlman Fellow Award, the inaugural Binkhorst Young Ophthalmologist Award from the American Society of Cataract and Refractive Surgery, the Kritzinger Memorial Award, Founder’s Award, and the Inaugural Recognition Award from the International Society of Refractive Surgery, and the Secretariat Award, Achievement Award, and Senior Achievement Award from the American Academy of Ophthalmology.
Dr. Randleman has served as Editor-in-Chief for the Journal of Refractive Surgery since 2011. He has authored more than 150 peer-reviewed publications in leading ophthalmology journals in addition to 40 book chapters on refractive surgery evaluation, corneal cross-linking, and management of complications with IOLs, and has authored four textbooks, Collagen Cross-Linking and Corneal Cross-Linking 2nd Edition, which he co-edited on Farhad Hafezi, MD, PhD, Refractive Surgery: An Interactive Case-Based Approach, and Intraocular Lens Surgery: Selection, Complications, and Complex Cases.
Education & Professional Highlights
Appointed
2019
Education & Fellowships
Fellowship - Emory Eye Clinic
Cornea External Disease and Refractive Surgery
Atlanta,
GA
2004
Residency - Emory Eye Clinic
Ophthalmology
Atlanta,
GA
2002
Internship - Atlanta Medical Center
Transitional Year Internship
Atlanta,
GA
1999
Medical Education - Texas Tech University School of Medicine
Lubbock,
TX
1998
Graduate School - Sam Houston State University
Graduate Studies in Biology
Huntsville,
TX
1994
Undergraduate - Columbia University
1992
Certifications
- Ophthalmology
Awards & Honors
1997 Junior Alpha Omega Alpha Medical Honor Society, Texas Tech SOM
1998 Merck Pharmaceuticals Quest for Excellence Award, Texas Tech SOM
2001 Outstanding Teaching Resident Award, Emory University
2004 Claes Dohlman Fellow Society (Outstanding Corneal Fellow in Nation)
2007 Secretariat Award, American Academy of Ophthalmology
2008 Achievement Award, American Academy of Ophthalmology
2010 Premier Surgeon P250 – inaugural member as leading innovator in premium IOL implant surgery
2010 Binkhorst Young Ophthalmologist Award, American Society of Cataract and Refractive Surgery
2011-present America’s Top Doctors (Ophthalmology), Castle Connolly, Ltd.
2011 Leading Ophthalmologists in America, named by Becker’s ASC Review
2011 Kritzinger Memorial Award, International Society of Refractive Surgery
2014 Senior Achievement Award, American Academy of Ophthalmology
2015 Recognition Award (Inaugural Award), International Society of Refractive Surgery
2016 Premier Surgeon 300 – leading innovator in premium refractive surgery, Ocular Surgery News
2016 Jose Ignacio Barraquer Award. Brazilian Society of Cataract and Refractive Surgery
2016 Atlanta’s Best Doctors, Atlanta Magazine
2016 Founder’s Award, International Society of Refractive Surgery
2017-2018 Top Doctors, Pasadena Magazine
2018 The Power List, The Ophthalmologist (Top 100 most influential people in the world of ophthalmology)
2018 Award of Excellence in Resident Education, USC Roski Eye Institute
2018 Secretariat Award, American Academy of Ophthalmology
2019 President’s Award, International Society of Refractive Surgery
Research & Publications
See publications for James Randleman, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 10/17/2024, Dr. Randleman has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
99 Patient Satisfaction Reviews
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.
| Overall | Star Ratings | |
|---|---|---|
| Explains | 4.6 | |
| Courtesy, Respect & Concern | 4.7 | |
| Patient Rating of Doctor | 4.6 |
6 Patient Comments
© 2024 The Cleveland Clinic Foundation. All Rights Reserved. No part of this work may be altered, reproduced, stored in a retrieval system, or transmitted, in any form, by any means, whether electronic, mechanical, by photocopying, recording, or otherwise, without the prior written permission of the Cleveland Clinic.
Reviewed on Nov 14, 2024
DR. RANDLEMAN WAS EXCELLENT!!!!!!
Reviewed on Nov 4, 2024
I had an amazing experience with the team and Dr. Randleman's office. From the second I walked into the office, everyone was so kind and helpful. The girl at the front desk, (sorry I cannot remember her name!) is one of the nicest, most helpful people, always greating us with a smile. Dr. Randleman and Dr. Marcellus are a great team & eased my nerves, so kind, comforting and thorough.
Reviewed on Apr 18, 2024
Dr. Randleman is top notch. Cole Eye Institute is fortunate to have him on staff. He is an excellent physician and great communicator.
Reviewed on Apr 3, 2024
Dr Randleman is phenomenal. He is very prompt, listens to my concerns and creates a camping atmosphere.
Reviewed on Mar 20, 2024
Physician was excellent. One office worker (Rayscaun) was absolutely amazing. He was kind and empathic, a real treasure to this office
Reviewed on Feb 22, 2024
I had just received a glasses prescription from another provider and Dr. Randelmans team found that it was too strong of a prescription. They helped me figure out how to exchange the lenses at no further cost to me which I greatly appreciated!